Price comparison of a box of Inavolisib and cost comparison of different versions
Inavolisib (Inavolisib), as a new type of targeted drug, is mainly used to treat specific types of cancer. The drug has been successfully launched in the country and has become one of the new treatment options for patients. However, at present, Inalise has not been included in the national medical insurance directory, so patients need to purchase it at their own expense, and the price is relatively high, which has become the focus of many patients.
In the domestic market, there are two main specifications of inaliset: 3mg7tablets4boards and 9mg7tablets4boards. Due to the short time the drug has been on the market, the price is still at a relatively high level, with the overall price per box being approximately RMB 30,000. This is undoubtedly a considerable financial burden for patients who require long-term medication. Therefore, patients and their families should fully evaluate their financial capabilities and treatment needs before deciding to take medication.

In comparison, the price of Inalise in overseas markets is more expensive. Affected by exchange rates and regional differences, the price of each box of Inalise may be as high as more than 200,000 yuan. The versions sold overseas are usually original drugs, and there are no generic drugs, so the price is difficult to significantly reduce. If patients choose imported drugs, they need to consider additional costs such as logistics and tariffs, and the overall cost will be higher.
Currently, there are no generic versions of Inarise on the market, which means there are no cheaper alternatives on the market. If patients need to use this drug, they should purchase it through regular channels and use it rationally under the guidance of a professional doctor. In the future, with the development of more related drugs and policy adjustments, the price of inalise is expected to be gradually optimized to help more patients obtain affordable treatment options.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)